300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Recruiting
Android
Proptech
Impact
Sustainability
Hardware
Web3
Biotech
Transportation
Enterprise
Community
Medical
Media (Entertainment)
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Europe
Bangladesh
Qatar
Angola
Cyprus
Barbados
Jordan
Belgium
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Bolivia
Faroe Islands
Jersey
Bahrain
Estonia
Belize
Bahamas
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Lithuania
Israel
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Elohim Partners, VC Fund

Elohim Partners

VC Fund

Seoul, South Korea

Elohim Partners is a private equity firm that mainly focuses on Asia middle-market buyouts and growth capital investments.

Total investments:
6
Last investment:
Lead investor:
17%

Last updated:

Industries Elohim Partners invests in

MedicalChemicalDatabaseRecyclingBiotechnology

Stages Elohim Partners invests in

Series ASeries CSeedSeries B

Countries Elohim Partners invests in

South KoreaUnited States

Investment Focus

Industry

  • Medical 1 (17%)
  • Chemical 1 (17%)
  • Database 1 (17%)
  • Recycling 1 (17%)
  • Biotechnology 1 (17%)
See all 13 industries →

Stage

  • Series A 2 (33%)
  • Series C 2 (33%)
  • Seed 1 (17%)
  • Series B 1 (17%)

Country

  • South Korea 3 (50%)
  • United States 1 (17%)

Investments

CompanyDescriptionRoundLinks
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology. $63.4M / Series A / Apr 21, 2026
Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology. $14.6M / Seed / Dec 10, 2024
LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future. $29M / Series C / Jun 18, 2024
EnergyX is a clean technology company that optimizes the lithium extraction process. The company was founded in 2018 and is headquartered in Fort Lauderdale, FL. $50M / Series B / Oct 15, 2023
LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future. $14.1M / Series A / Aug 16, 2022
Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer. $11.8M / Series C / Oct 14, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Recruiting
Android
Proptech
Impact
Sustainability
Hardware
Web3
Biotech
Transportation
Enterprise
Community
Medical
Media (Entertainment)
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Europe
Bangladesh
Qatar
Angola
Cyprus
Barbados
Jordan
Belgium
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Bolivia
Faroe Islands
Jersey
Bahrain
Estonia
Belize
Bahamas
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Lithuania
Israel
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Elohim Partners invest in?

Elohim Partners invests primarily in Medical, Chemical and Database startups, most often at Series A and Series C stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Elohim Partners last invest?

The most recent investment recorded for Elohim Partners closed in Apr 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Elohim Partners Elohim Partners Find emails